Capivasertib treatment associated with hypermetabolism of the spleen

Abstract Capivasertib has emerged as a promising treatment for advanced breast and prostate cancer. Here, we report two cases of metastatic breast cancer patients who developed splenic hypermetabolism on [18 F]-FDG PET/CT following treatment with capivasertib. To our knowledge, these are the first d...

Полное описание

Библиографические подробности

Главные авторы:	Maria Ly, Gary Z. Yu, Amin Haghighat Jahromi
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Springer 2025-03-01
Серии:	EJNMMI Reports
Предметы:	Capivasertib Splenic hypermetabolism Side effect [18F]-FDG PET/CT
Online-ссылка:	https://doi.org/10.1186/s41824-024-00231-7
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!